#JubilantIngrevia Planned Capex of Rs. 900 Cr. in next 3 yrs.
— Mouzam (@mmali09) March 30, 2021
Entry into Diketene derivatives -game changer.
- Import substitution opp. (40% is imported)
- used in Pharma & Agro Chem
- currently at 50% discount to competitor in India
- one of the leading Int. supplier Exit https://t.co/etPtndC1xN pic.twitter.com/WRQUFXHAtR
#JUBLINGREA #FY21AR Compiled together some interesting insights from various pages.
Its an extremely informative AR with broad industry & segment wise overview. MUST READ
Lot of moving parts but looks very optimistic & strong growth outlook.
https://t.co/MxuTZDUfFT

#JubilantIngrevia
— Mouzam (@mmali09) June 24, 2021
\U0001f44cAcquisition of 385,100 equity shares worth Rs 21.36 Cr by the promoter group.
Promoter buying is a Big Positive\U0001f3af
Shows that he is confident about its prospects and believes that investing in the company is better than putting money somewhere else.\U0001f4aa\U0001f4c8 https://t.co/vNYcSr3RgV pic.twitter.com/0WnXGN0UYZ
#JUBLINGREA
— Mouzam (@mmali09) July 20, 2021
Super Result\U0001f680QoQ/YoY
Despite covid issues
YoY
Rev 1145Cr vs 737cr (+55%)
EBTDA 25% vs 17%
PAT 168cr vs 53cr (+220%)
EPS 10.6 vs 3.3
\U0001f525All 3 engines
\U0001f9eaInteresting Key CAPEX:
- Dietene on schedule
- CDMO GMP - new
- 2 Multipurpose Spl. Chemical plants new https://t.co/vNYcSr3RgV pic.twitter.com/0rcmB1YMfM
Bio-Acetaldehyde - Bio based \U0001f9ec, World\u2019s largest manufacturer from \U0001f1ee\U0001f1f3
— Punit (@punitbansal14) July 28, 2021
Image 1: Benefit in carbon footprint as compared to the conventional petroleum route
Image 2: Bio-Acetaldehyde business overview pic.twitter.com/7M2Eqz5maS
Image 1: Paracetamol is made by reacting para-aminophenol with acetic anhydride
— Punit (@punitbansal14) August 29, 2021
Image 2 & 3: MS of acetic anhydride in India is 71%, some of top producers of Paracetamol are nearly 100% dependent on them
Image 4: One of the World\u2019s largest Paracetamol API facilities also in \U0001f1ee\U0001f1f3 https://t.co/arqfH7H5tE pic.twitter.com/OURNqDofzK
More from Jubliantingrevia
💥 11% Up
Trading at ATH
#jubilantingrevia #jubilingrea
— Sk Parbesh\U0001f1ee\U0001f1f3\U0001f4ca\U0001f4c8\U0001f4c9 (@Chart_View) July 21, 2021
Breakout from tight consolidation with highest daily volume exactly from support
Posted Excellent Q1 Result
Good Setup to go long
CMP: 589
Weakness below: 540 DCB@nid_rockz https://t.co/03RvbA2oZy pic.twitter.com/Vl6Rk52noY
#JUBLINGREA
Updated Chart

695 to 730 https://t.co/MbxPEvUYgl

Jubilant Ingrevia - will be looking to scale this up further. Pyramiding. Coming back once more near 20 MA. https://t.co/mulUpbf4Mn pic.twitter.com/vL1oKc92nL
— The_Chartist \U0001f4c8 (@nison_steve) September 7, 2021
You May Also Like
Always. No, your company is not an exception.
A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.
Listen to Aditya
"we don't negotiate salaries" really means "we'd prefer to negotiate massive signing bonuses and equity grants, but we'll negotiate salary if you REALLY insist" https://t.co/80k7nWAMoK
— Aditya Mukerjee, the Otterrific \U0001f3f3\ufe0f\u200d\U0001f308 (@chimeracoder) December 4, 2018
And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.
I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.
You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.
Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]